In SMMC-7721 human hepatoma cells, TMEM16A knockdown reduced the p38 and ERK1/2 phosphorylation, but not JNK phosphorylation, suggesting that TMEM16A activated the p38 and ERK1/2 signaling pathways [52]. The gene discussed is ANO1; the disease is hepatocellular carcinoma.